COMBINATION THERAPY USING TRANSFERRIN FUSION PROTEINS COMPRISING GLP-1
摘要
<p>The present invention provides combination therapy comprising transferrin fusion protein and DPP-IV inhibitors and/or neutral endopeptidase (NEP) inhibitors. The transferrin fusion protein comprises therapeutic polypeptides or peptides useful in the treatment of diseases such as diabetes.</p>
申请公布号
WO2006017688(A2)
申请公布日期
2006.02.16
申请号
WO2005US27800
申请日期
2005.08.03
申请人
BIOREXIS PHARMACEUTICAL CORPORATION;SADEGHI, HOMAYOUN;PRIOR, CHRISTOPHER;BALANCE, DAVID, J.
发明人
SADEGHI, HOMAYOUN;PRIOR, CHRISTOPHER;BALANCE, DAVID, J.
